Mar 25, 2025 07:00AM
Nov 8, 2024 07:00AM
Aug 9, 2024 07:00AM
May 10, 2024 07:00AM
Apr 11, 2024 07:04AM
Apr 11, 2024 07:00AM
Mar 25, 2024 07:00AM Kiora Pharmaceuticals Reports 2023 Results; Continues to Advance Pipeline of Treatments for Rare Retinal Diseases
Mar 8, 2024 07:02AM
Mar 8, 2024 07:00AM
Nov 9, 2023 07:18AM
Nov 4, 2023 12:15PM
Aug 23, 2023 07:02AM
Aug 23, 2023 07:00AM
Aug 8, 2023 07:00AM Kiora Pharmaceuticals Announces Q2 2023 Earnings and Business Update, Highlighting Pipeline Updates and Clinical Development Progress
May 9, 2023 07:00AM
Mar 23, 2023 07:03AM
Mar 23, 2023 07:00AM
Jan 3, 2023 07:01AM
Nov 9, 2022 06:45AM
Aug 12, 2022 06:45AM
Apr 27, 2022 03:29PM ARUNA BIO APPOINTS STEPHEN FROM AS CHIEF EXECUTIVE OFFICER
Apr 15, 2022 09:03AM
Apr 15, 2022 09:00AM
Mar 18, 2022 06:47AM
Mar 18, 2022 06:45AM
Jan 19, 2022 09:36AM
Dec 14, 2021 07:17AM
Dec 14, 2021 07:15AM Kiora Reports KIO-101 is Safe and Tolerable; Topline Data Supports Advancing KIO-101 to a Phase 2 Study in Patients with Dry Eye Disease
Nov 15, 2021 07:30AM
Nov 8, 2021 07:35AM
Nov 8, 2021 07:30AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All